A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 26, 2011

Primary Completion Date

July 2, 2012

Study Completion Date

July 2, 2012

Conditions
Coronary Artery Disease (CAD)
Interventions
DRUG

regadenoson

Administered by intravenous bolus.

RADIATION

technetium Tc99m sestamibi /technetium Tc99m tetrafosmin

Administered by intravenous infusion

RADIATION

Contrast

Administered by intravenous infusion.

PROCEDURE

Single Photon Emission Computed Tomography

Procedure/Surgery

PROCEDURE

Multidetector Computed Tomography

Procedure/Surgery

Trial Locations (11)

33173

Cardiovascular Research Center of South Florida, Miami

33176

Baptist Hospital of Miami, Miami

48202

Henry Ford Health System, Detroit

66029

Midwest Cardiology Associates, P.C., Overland Park

90502

Harbor UCLA Medical Center, Torrance

95661

Sutter Roseville Medical Center, Roseville

97239

Oregon Health and Science University, Portland

04210

Maine Research Associates, Auburn

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

01201

Berkshire Medical Center, Pittsfield

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01334918 - A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) | Biotech Hunter | Biotech Hunter